To the Editor:
Dysplastic findings in blood cells arise due to any challenge during the course of normal differentiation and can be encountered in autoimmune disorders (1) (2) (3) .
Some myelodysplastic findings closely overlap with features of cellular senescence, which may be dependent on or independent of telomeres. The latter case is due to severe DNA damage, oncogenes, oxidative stress, and strong mitogenic signals (4) .
No hallmark of senescence has been identified yet. Salient features of senescent cells are: 1) permanent growth arrest (generally in G1); 2) increased cell size and polyploidy; 3) expression of senescence-associated β-galactosidase (SA-β-gal) activity; 4) expression of p16INK4a in some of them, which causes reorganization of heterochromatin as punctate highly condensed domains of facultative heterochromatin [(senescence-associated heterochromatin foci (SAHF)] that silence critical proproliferative genes; 5) DNA damage response (DDR), which initiates and maintains the senescence growth arrest; and 6) secretion of growth factors, proteases, and cytokines by senescent cells with persistent DDR signaling (senescence-associated secretory phenotype) (5). Alterations in cell cycle and reorganization in the genome is accompanied by altered cytokinesis, karyokinesis, cellular scaffolding and alterations in cell morphology, formation of micronuclei (6) or fragmented nuclei, flattened cell shape, and intracellular vacuoles (7) (8) (9) .
Herein, we aimed to investigate the coexistence of cellular senescence with myelodysplastic findings in patients with juvenile rheumatoid arthritis (JRA, n = 2), systemic lupus erythematosus (SLE, n = 1), acute immune thrombocytopenic purpura (ITP, n = 1) and chronic ITP (n = 1). SLE and chronic ITP patients were not on any therapy for at least 45 days; the others were at first admission (age: 11.6 ± 4.61 years; 2 females, 3 males; controls: 13.66 ± 4.16). The leukocytes were prepared and stained by SA-β-gal (8) .
All patients had dysmorphic blood cells on blood smears (up to 80% vs. 25% in the controls). The leukocytes of all patients displayed positive SA-β-gal staining (by 33%-57% vs. 0% in the controls) (Figure 1) .
In our patients, we could not test all features of cellular senescence, but not all senescent cells express all possible senescence markers (5). In our patients, SA-β-gal positivity, increased cell size and increased chromatin clumping, which mimics nuclear fragmentation (10), and SAHF are compatible with cellular senescence.
We think that the proinflammatory cytokines and chemokines in SLE, JRA-PT, and ITP patients (11-13) led to cellular senescence (14) by keeping the immune system in a state of chronic low-level activation and giving rise to immunosenescence through loss of telomeres with each S phase (5), which was increased by inflammatory mediators that are secreted by senescent cells themselves (14) . Additionally, destruction of tissue environment and stem cell niches (14) by inflammatory mediators, proteases, and immune cells may have exacerbated aging through hematopoietic stem cell dysfunction, altered mitosis, and dysmorphism.
Essentially, decline in absolute number of T (CD8+, CD4+) and B lymphocytes (15) in immunosenescence, abnormal telomere/telomerase system in ITP (16) , and accelerated loss of T cells in juvenile idiopathic arthritis (17) were reported.
In conclusion, these results suggest that cellular senescence plays a role in the pathogenesis of autoimmune disorders and myelodysplastic features may be a reflection of cellular senescence. Further studies are needed for confirmation. 
